Nantong Jinghua Pharmaceutical Co Ltd002349
± MixedCapitalrelevance
CFO resignation and replacement; no material impact on operations or financials indicated.
Impact on stocks 1
Others
Nantong Jinghua Pharmaceutical Co LtdJinghua Pharmaceutical announced that Chief Financial Officer Cheng Jian has resigned due to a job reassignment, but will remain as a director and general manager. Cheng Jian holds 770,000 shares in the company, and the resignation will not affect normal operations. The board has approved the appointment of Zhao Li as the new CFO, with a term starting from the date of this board resolution until the end of the sixth board's term. In the first quarter of 2026, Jinghua Pharmaceutical reported revenue of 380 million yuan and net profit attributable to the parent of 65.87 million yuan.
Nantong Jinghua Pharmaceutical Co LtdCFO resignation and replacement; no material impact on operations or financials indicated.